What tests should be included in a comprehensive pneumonitis work‑up panel?

Pneumonitis Panel: Comprehensive Diagnostic Work-Up

A comprehensive pneumonitis panel should include: high-resolution CT chest (HRCT), bronchoalveolar lavage (BAL) with lymphocyte cellular analysis, serum IgG testing against suspected antigens, detailed exposure history using a structured questionnaire, and consideration of lung biopsy (transbronchial or surgical) when initial testing is non-diagnostic. 1

Core Diagnostic Components

Imaging

• HRCT chest is essential as the initial imaging modality for all suspected pneumonitis cases
• HRCT demonstrates superior sensitivity compared to standard chest radiography (45% vs 9% detection rate in population studies) 2
• Look specifically for mosaic attenuation patterns and poorly defined centrilobular nodules, which are highly suggestive findings 3, 2

Exposure Assessment

• Obtain detailed exposure history focusing on occupational, environmental, and home exposures (birds, mold, hot tubs, humidifiers, agricultural exposures)
• Use a structured questionnaire when available - these detect 100% of relevant exposures versus only 26% detected by routine clinical history 4
• Document timing relationship between exposure and symptom onset, as temporal correlation significantly increases diagnostic confidence 3

Serologic Testing

• Perform serum IgG testing targeting antigens associated with suspected exposures (avian proteins, thermophilic actinomycetes, fungal antigens) 1
• Important caveat: Serum IgG has excellent sensitivity (90-92%) and specificity (91-100%) for distinguishing HP from healthy controls, but performs poorly (83% sensitivity, 68% specificity) in differentiating HP from other interstitial lung diseases 4
• Positive IgG indicates exposure but does not confirm disease; negative IgG does not exclude HP

Bronchoalveolar Lavage

• BAL with lymphocyte cellular analysis is recommended for both nonfibrotic and fibrotic HP phenotypes 1
• Lymphocytosis >20% supports HP diagnosis, though absence does not exclude it
• BAL also helps exclude infection and malignancy

Tissue Diagnosis

The approach differs by clinical phenotype:

For Nonfibrotic HP:

• Transbronchial forceps biopsy is suggested as initial tissue sampling 1
• Surgical lung biopsy reserved only when all other testing is non-diagnostic
• Look for poorly formed non-necrotizing granulomas, which carry high diagnostic weight 3

For Fibrotic HP:

• Transbronchial cryobiopsy is suggested as it provides larger samples 1
• Surgical lung biopsy considered when diagnosis remains uncertain after less invasive testing
• Histologic findings of granulomas significantly increase diagnostic confidence 2

Drug-Related Pneumonitis Considerations

When drug-induced pneumonitis is suspected (particularly with molecular targeting agents, immune checkpoint inhibitors, or chemotherapy):

• Review complete medication history including cancer drugs, immunosuppressants (methotrexate), amiodarone, and nitrofurantoin 5
• Document temporal relationship between drug initiation and symptom onset
• Note that onset can be delayed (sometimes >10 years with agents like carmustine) 5
• HRCT patterns may differ from hypersensitivity pneumonitis

Diagnostic Algorithm

1. Initial evaluation: HRCT chest + detailed exposure history with structured questionnaire
2. Serologic testing: Serum IgG panel based on identified exposures
3. Bronchoscopy: BAL with lymphocyte differential (consider transbronchial biopsy)
4. Multidisciplinary discussion: Integrate clinical, radiographic, and laboratory findings
5. Tissue diagnosis: If diagnosis uncertain, proceed to cryobiopsy or surgical biopsy based on fibrosis presence

Critical Pitfalls to Avoid

• Do not rely on chest radiography alone - it misses 55% of cases that HRCT detects 2
• Do not interpret positive serum IgG as diagnostic - it only indicates exposure; 70% of questionnaire-identified exposures fail environmental confirmation 4
• Do not skip exposure assessment - identifying and removing the causative antigen is fundamental to management and directly impacts morbidity 3
• Do not assume all pneumonitis is hypersensitivity pneumonitis - maintain high suspicion for drug-induced causes, especially in patients on chemotherapy or immunotherapy 5

The diagnostic confidence increases substantially when multiple elements align: identified exposure with temporal correlation, characteristic HRCT findings (mosaic attenuation, centrilobular nodules), BAL lymphocytosis, and histologic granulomas 3.